Last updated 2026-09-06
- Acquired by Intelicanna Ltd., Mar 2019
- Raised $4M Undisclosed Round led by Ori Weiss, Feb 2019
- Raised Undisclosed Round, Jan 2020
Total raised
$4.0M
Last: Undisclosed Round 2017-01
Stage
Mature
Founded
2014
Headcount
8
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
Alvit LCS Pharma was founded in 2014 with the goal of researching and developing cannabis-based pharmaceutical products. The company has developed a broad line of pharma-grade cannabis products including tablets, sprays, and suppositories, several of which have completed or been approved for clinical trials in Israel. Alvit controls the entire lifecycle of the cannabis drug development process, from EU-GMP cultivation of proprietary cannabis clones to advanced drug delivery and global commercialization initiatives. They also have international initiatives in Malta and Germany for cultivation, manufacturing, marketing, and distribution.
Funding history · 2 rounds · $4.0M total
2 events/rounds · $4.0M Total Funding: $4.0M in Private Equity
Jan 2020
Feb 2019
★ Ori Weiss★ Saul Kaye★ Leon Recanati★ Sitrin Capital★ Alvit LCS Pharma★ Gary Leibler (Shavit Capital)★ Yaki Amsalem (from Almog Group)
Headcount over time
8 employees (2026-09) · 1 point
Offices
Tel Aviv-Yafo, Israel · HQ / main office
Q&A
- What is Alvit LCS Pharma's primary focus?
- Alvit LCS Pharma is a vertically integrated medical cannabis research and development company specializing in pharmaceutical-grade cannabis product development and drug-delivery technologies.
- What types of products does Alvit LCS Pharma develop?
- Alvit LCS Pharma's products include various types of tablets, sprays, and suppositories, focusing on pharmaceutical-grade cannabis.
- When was Alvit LCS Pharma founded?
- Alvit LCS Pharma was founded in April 2014.
- How many employees does Alvit LCS Pharma have?
- Alvit LCS Pharma has 1-10 employees.
- Has Alvit LCS Pharma participated in any funding rounds?
- Alvit LCS Pharma had a funding round in January 2017 with Oded Zucker as an investor.
- What was a significant corporate development for Alvit LCS Pharma in late 2018?
- In November 2018, Alvit LCS Pharma announced the merger of its cannabis growing activity into Intelicann, a cannabis cultivation facility in Israel that is publicly traded on the Tel Aviv Stock Exchange.
- Who are the co-founders of Alvit LCS Pharma?
- The co-founders of Alvit LCS Pharma are Itschak Lamensdorf, Nachshol Cohen (Co-founder & CSO), and Yoram Sela (Co-founder & VP R&D).
- What is the current stage of Alvit LCS Pharma?
- Alvit LCS Pharma is currently in the Mature stage.
Team · 8
Nachshol Cohen
Founder · CSO
Dr. Itschak Lamensdorf
Founder · Founder
Dr. Yoram Sela
Founder · Founder
Yona Levy
CEO
Dr. Eran Blaugrund
Head of Pharmacology
Gavin B. Samuels
Advisor
Prof. Dan Peer
Advisor
Gary Liebler
Board Observer
Sectors & technology
Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Business model
B2B
Tags
medical-cannabispharmaceuticalsdrug-deliverypatientscannabis
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | alvitpharma.com/ |
|---|---|
| linkedin.com/company/11741297 | |
| facebook.com/Alvit-LCS-Pharma-540309976489069 |
Identifiers & details
| Founded | 2014 |
|---|---|
| Employees (exact) | 8 |
Acquisitions & public offerings
Acquired by Intelicanna Ltd. 2019-03
Radar intelligence
Patents
| EPO | 4 |
|---|
Web history (Wayback)
| Domain | alvitpharma.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515072056 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2014-04-24 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2022 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | קורא הדורות 26 ירושלים |